Mounjaro
tirzepatide
GIP and GLP-1 receptor agonist
Prescription requiredUnderstand reviewed ingredients, approved uses, formulations and pharmacy acquisition benchmarks.
tirzepatide
GIP and GLP-1 receptor agonist
Prescription requiredsemaglutide
GLP-1 receptor agonist
Prescription requiredShared ingredients, classes or uses do not establish interchangeability or identical eligibility.
Ozempic contains semaglutide. Mounjaro contains tirzepatide. A shared ingredient does not establish interchangeability.
Class membership does not establish clinical alternatives.
The reviewed uses and their qualifications differ. Shared use concepts do not mean identical eligibility.
Mounjaro: injection, once weekly. Ozempic: injection, once weekly. Ozempic: tablet, once daily. Routine frequency does not describe dose or titration.
Historical NADAC trends are available within individual products. They are not retail or patient prices and cannot rank these medicines by cost.
This comparison provides factual information and does not recommend a treatment. Treatment decisions belong with a qualified healthcare professional.
This snapshot does not assess complete contraindications, interactions or adverse effects.
For individual product information, read the Ozempic medication reference and Mounjaro medication reference.
For further treatment context, see Ozempic Side Effects and Tirzepatide Dosing.
For personal payment and coverage questions, use our US Ozempic vs Mounjaro cost comparison, including links to detailed self-pay guides.